BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28607018)

  • 1. Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.
    Bauwens A; Kunsmann L; Karch H; Mellmann A; Bielaszewska M
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitness of Enterohemorrhagic Escherichia coli (EHEC)/Enteroaggregative E. coli O104:H4 in Comparison to That of EHEC O157: Survival Studies in Food and In Vitro.
    Böhnlein C; Kabisch J; Meske D; Franz CM; Pichner R
    Appl Environ Microbiol; 2016 Nov; 82(21):6326-6334. PubMed ID: 27542931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
    Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
    Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahost milieu modulates production of outer membrane vesicles, vesicle-associated Shiga toxin 2a and cytotoxicity in Escherichia coli O157:H7 and O104:H4.
    Bauwens A; Kunsmann L; Marejková M; Zhang W; Karch H; Bielaszewska M; Mellmann A
    Environ Microbiol Rep; 2017 Oct; 9(5):626-634. PubMed ID: 28675605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
    Zhang X; McDaniel AD; Wolf LE; Keusch GT; Waldor MK; Acheson DW
    J Infect Dis; 2000 Feb; 181(2):664-70. PubMed ID: 10669353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of epigallocatechin gallate and citric acid on Escherichia coli O157:H7 toxin gene expression and virulence-associated stress response.
    Yang J; Tang CB; Xiao J; Du WF; Li R
    Lett Appl Microbiol; 2018 Nov; 67(5):435-441. PubMed ID: 30066955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.
    Kijewski A; Witsø IL; Iversen H; Rønning HT; L'Abée-Lund T; Wasteson Y; Lindbäck T; Aspholm M
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32769190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak.
    Corogeanu D; Willmes R; Wolke M; Plum G; Utermöhlen O; Krönke M
    BMC Microbiol; 2012 Aug; 12():160. PubMed ID: 22853739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.
    Bielaszewska M; Idelevich EA; Zhang W; Bauwens A; Schaumburg F; Mellmann A; Peters G; Karch H
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3277-82. PubMed ID: 22391549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
    Kurioka T; Yunou Y; Harada H; Kita E
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
    Grif K; Dierich MP; Karch H; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.
    Ko H; Maymani H; Rojas-Hernandez C
    J Med Case Rep; 2016 Jun; 10():175. PubMed ID: 27301547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles.
    Choi KS; Kim SH; Kim ED; Lee SH; Han SJ; Yoon S; Chang KT; Seo KY
    PLoS One; 2014; 9(7):e100229. PubMed ID: 25032703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA microarray-based assessment of virulence potential of Shiga toxin gene-carrying Escherichia coli O104:H7 isolated from feedlot cattle feces.
    Shridhar PB; Patel IR; Gangiredla J; Noll LW; Shi X; Bai J; Elkins CA; Strockbine N; Nagaraja TG
    PLoS One; 2018; 13(4):e0196490. PubMed ID: 29708991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.
    Zhang Q; Donohue-Rolfe A; Krautz-Peterson G; Sevo M; Parry N; Abeijon C; Tzipori S
    J Infect Dis; 2009 Feb; 199(4):486-93. PubMed ID: 19125676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.